COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 785: Articles 7841-7850  | Next

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery
Milazzo, F. M., Chaves-Sanjuan, A., Minenkova, O., Santapaola, D., Anastasi, A. M., Battistuzzi, G., Chiapparino, C., Rosi, A., Merlo Pich, E., Albertoni, C., Marra, E., Luberto, L., Viollet, C., Spagnoli, L. G., Riccio, A., Rossi, A., Santoro, M. G., Ballabio, F., Paissoni, C., Camilloni, C., Bolognesi, M., De Santis, R.
10.1101/2022.05.27.493569 — Posted: 2022-05-27
Immunogenicity and Safety of Beta Adjuvanted Recombinant Booster Vaccine
LAUNAY, O., Cachanado, M., Luong Nguyen, L. B., Ninove, L., Lachatre, M., Ben Ghezala, I., Bardou, M., Schmidt -Mutter, C., Felten, R., Lacombe, K., Surgers, L., Laine, F., Allain, J.-S., Botelho-Nevers, E., Tavolacci, M.-P., Chidiac, c., Pavese, P., Dussol, B., Priet, S., Deplanque, D., Touati, A., Curci, L., Konate, E., Ben Hamouda, N., Besbes, A., Nubret, E., Capelle, F., Berard, L., Rousseau, A., Tartour, E., Simon, T., De Lamballerie|, X.
10.1101/2022.05.25.22274904 — Posted: 2022-05-27
Facing the Omicron variant - How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Kuelper-Schiek, W., Piechotta, V., Pilic, A., Batke, M., Dreveton, L.-S., Geurts, B., Koch, J., Koeppe, S., Treskova, M., Vygen-Bonnet, S., Waize, M., Wichmann, O., Harder, T.
10.1101/2022.05.25.22275516 — Posted: 2022-05-27
How is the COVID-19 pandemic impacting our life, mental health, and well-being? Design and preliminary findings of the pan-Canadian longitudinal COHESION Study
Gabet, S., Thierry, B., Wasfi, R., De Groh, M., Simonelli, G., Hudon, C., Lessard, L., Dube, E., Nasri, B., Kestens, Y., Moullec, G.
10.1101/2022.05.26.22275645 — Posted: 2022-05-27
A rapid One-Pot RNA-isolation method for simplified clinical detection of SARS-COV-2 infection in India
Jain, S., Bhowmick, A., Pandey, A. K.
10.1101/2022.05.26.22275661 — Posted: 2022-05-27
Epidemiological Interactions of Influenza and SARS-CoV-2 within a University Population During Omicron B.1.1.529 Outbreak
Malampy, R., Ganz, T., DeOliveira, G. M., Le, C. T., Li, K. M., Auclair, J.
10.1101/2022.05.26.22275641 — Posted: 2022-05-27
Molecular Investigations of Selected Spike Protein Mutations in SARS-CoV-2: Delta and Omicron Variants and Omicron BA.2 Sub Variant
Roy, U.
10.1101/2022.05.25.493484 — Posted: 2022-05-26
How do local-level authorities engage in epidemic and pandemic preparedness activities and coordinate with higher levels of government? Survey results from 33 cities
Boyce, M. R., Asprilla, M. C., van Loenen, B., McClelland, A., Rojhani, A.
10.1101/2022.05.25.22275614 — Posted: 2022-05-26
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational study
Wong, C. K. H., Au, I. C. H., Lau, K. T. K., Lau, E. H. Y., Cowling, B. J., Leung, G. M.
10.1101/2022.05.26.22275631 — Posted: 2022-05-26
Virologic characterization of symptom rebound following nirmatrelvir-ritonavir treatment for COVID-19
Boucau, J., Uddin, R., Marino, C., Regan, J., Choudhary, M. C., Flynn, J. P., Chen, G., Stuckwisch, A. M., Mathews, J., Liew, M. Y., Singh, A., Reynolds, Z., Iyer, S. L., Chamberlin, G. C., Vyas, T. D., Vyas, J. M., Turbett, S. E., Li, J. Z., Lemieux, J. E., Barczak, A. K., Siedner, M. J.
10.1101/2022.05.24.22275326 — Posted: 2022-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).